News

Check out market updates

MiRagen rebrands to Veridian months after acquisition, names new CEO

BOULDER — Biopharmaceutical maker miRagen Therapeutics Inc. (Nasdaq: MGEN) has made its biggest moves yet after a tumultuous several months, […]
Source: BizWest

Leave a Reply

Your email address will not be published. Required fields are marked *

X